RGLG3 Antibody

What is RGLG3 and what is its role in plant hormone signaling?

RGLG3 belongs to the RING DOMAIN LIGASE family (RGLG1-5) in Arabidopsis thaliana and functions as an E3 ubiquitin ligase. Research has demonstrated that RGLG3, together with RGLG4, serves as an essential regulator of the jasmonate signaling pathway . Unlike RGLG1 and RGLG2, which affect auxin and cytokinin levels, or RGLG1 and RGLG5, which interact with PP2CA to regulate ABA signaling, RGLG3 has specialized functions in jasmonate responses. Understanding these distinct regulatory roles is crucial for researchers developing antibodies against specific RGLG family members.

How can I verify the specificity of an anti-RGLG3 antibody?

Verifying antibody specificity for RGLG3 requires multiple validation approaches:

• Western blot analysis with recombinant RGLG3 protein as a positive control

• Cross-reactivity testing against other RGLG family members (especially RGLG4)

• Immunoprecipitation followed by mass spectrometry to confirm target protein identity

• Testing in RGLG3 knockout/knockdown plants to verify signal reduction

When selecting validation methods, consider that RGLG family members share sequence similarities. For instance, while RGLG1 and RGLG5 both interact with PP2CA, they show selectivity for certain clade A PP2Cs but not others , suggesting structural differences that could be exploited for generating specific antibodies.

What is the recommended sample preparation protocol for RGLG3 immunodetection?

For optimal RGLG3 immunodetection in plant tissues:

• Tissue harvesting: Collect fresh plant tissues and flash-freeze in liquid nitrogen

• Protein extraction: Use a buffer containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100

  • 0.5% sodium deoxycholate

  • 1 mM EDTA

  • Protease inhibitor cocktail

  • 10 mM N-ethylmaleimide (to preserve ubiquitination)

• Sample handling: Maintain samples at 4°C throughout extraction

• Protein quantification: Bradford or BCA assay

• Denaturation: Heat samples at 95°C for 5 minutes in Laemmli buffer with DTT

Consider that treatment with hormones such as jasmonate may affect RGLG3 expression or localization. Similar to how ABA treatment enhances the interaction between RGLG1/5 and PP2CA , jasmonate treatment may affect RGLG3 detection.

What are the key differences between RGLG3 and other RGLG family proteins that may affect antibody development?

While all RGLG proteins contain a RING domain necessary for E3 ligase activity (as demonstrated for RGLG5 ), they differ in their targets and regulation. These differences provide potential epitope regions for specific antibody generation.

How do hormone treatments affect RGLG3 expression and detection?

Hormone treatments significantly impact RGLG protein expression and interactions. For RGLG3, which regulates jasmonate signaling, treatment with methyl jasmonate (MeJA) likely affects its expression, localization, or activity. By comparison, ABA treatment dramatically enhances the interaction between RGLG1/5 and PP2CA, as demonstrated by coimmunoprecipitation assays where the interaction was weak without ABA but significantly strengthened with 10 μM ABA .

When designing experiments with RGLG3 antibodies:

• Include appropriate hormone treatments (particularly jasmonates)

• Establish time-course experiments to determine optimal detection windows

• Consider that hormone cross-talk may influence RGLG3 detection

• Include appropriate controls (hormone-treated vs. untreated samples)

How can I design epitope-specific antibodies to distinguish between RGLG3 and the closely related RGLG4?

Developing antibodies that specifically recognize RGLG3 and not RGLG4 requires strategic epitope selection:

• Sequence alignment analysis: Identify non-conserved regions between RGLG3 and RGLG4

• Structural prediction: Use algorithms to predict surface-exposed regions unique to RGLG3

• Epitope design considerations:

  • Select peptides 10-20 amino acids in length

  • Avoid hydrophobic regions

  • Target regions with high predicted antigenicity

  • Consider post-translational modifications that may be unique to RGLG3

Modern antibody design approaches like IgSeek can be adapted for this purpose, as they employ "a novel structure-retrieval framework that infers sequences by retrieving similar structures from a natural antibody database" , which could potentially be applied to identifying optimal epitopes for RGLG3.

What are the most effective methods for detecting RGLG3-mediated ubiquitination in plant samples?

Detecting RGLG3-mediated ubiquitination requires specialized techniques:

• In vivo ubiquitination assays:

  • Immunoprecipitate the suspected target protein

  • Perform western blot with anti-ubiquitin antibodies

  • Include N-ethylmaleimide in all buffers to inhibit deubiquitinating enzymes

• In vitro ubiquitination assays:

  • Express and purify recombinant RGLG3 (similar to GST-RGLG5 approach )

  • Combine with E1, E2 enzymes, ubiquitin, and suspected substrate

  • Detect ubiquitination by western blot

• Ubiquitin chain-specific detection:

  • Use antibodies specific for different ubiquitin linkages (K48, K63, etc.)

  • RGLG2 catalyzes K63-linked chains with MMZ2/UBC35 , suggesting RGLG3 may have similar specificity

• Mass spectrometry-based approaches:

  • Identify ubiquitination sites and chain types

  • Can validate direct RGLG3 targets

How can phosphorylation state affect RGLG3 antibody binding and what controls should be implemented?

Phosphorylation can significantly impact antibody recognition of RGLG3:

• Potential impacts:

  • Phosphorylation may create or mask antibody epitopes

  • May alter RGLG3 conformation affecting antibody accessibility

  • Could change protein-protein interactions affecting co-IP experiments

• Recommended controls:

  • Treatment with lambda phosphatase to remove phosphorylation

  • Comparison of samples from plants under different stress conditions

  • Parallel detection with phosphorylation-sensitive and insensitive antibodies

• Experimental considerations:

  • Include phosphatase inhibitors during extraction if studying phosphorylated forms

  • For RGLG3, consider that jasmonate signaling often involves phosphorylation cascades

  • Develop phospho-specific antibodies for key regulatory sites

The ABA-enhanced interaction between RGLG1/5 and PP2Cs suggests hormone signaling can affect protein interactions, potentially through phosphorylation states.

What are the current challenges in studying RGLG3 and RGLG4 functional redundancy using antibody-based approaches?

Studying functional redundancy between RGLG3 and RGLG4 presents several challenges:

• Antibody cross-reactivity:

  • High sequence similarity makes specific detection difficult

  • Validation in single and double mutants is essential

• Compensation mechanisms:

  • Knockout of one gene may alter expression of the other

  • Changes in protein levels require quantitative immunoblotting

• Tissue-specific expression differences:

  • May require tissue-specific immunolocalization

  • Consider developing tissue-specific assays

• Methodological solutions:

  • Use epitope-tagged versions of each protein in complementation studies

  • Combine antibody approaches with genetic tools (CRISPR/Cas9)

  • Develop antibodies against unique post-translational modifications

How can chromatin immunoprecipitation (ChIP) be optimized for studying RGLG3's role in transcriptional regulation?

While E3 ligases like RGLG3 are not typically DNA-binding proteins, they may regulate transcription through interaction with transcription factors:

• Optimized ChIP protocol for RGLG3:

  • Crosslinking: Use dual crosslinking (DSG followed by formaldehyde)

  • Sonication: Optimize conditions for plant chromatin (typically requiring longer sonication)

  • IP conditions: Use high-salt washes to reduce background

  • Controls: Include IgG control and input samples

• Sequential ChIP approach:

  • First IP: Target known transcription factors in jasmonate pathway

  • Second IP: Use RGLG3 antibody to identify co-occupied regions

• Data analysis considerations:

  • Compare results with transcriptome data from rglg3 mutants

  • Validate with reporter gene assays

What are the best expression systems for producing recombinant RGLG3 for antibody production?

Selection of an appropriate expression system is critical for generating functional RGLG3 antigen:

• E. coli expression:

  • Advantages: High yield, cost-effective

  • Disadvantages: Potential misfolding, lack of post-translational modifications

  • Optimization: Use solubility tags (MBP, SUMO), low induction temperature

• Insect cell expression:

  • Advantages: Better folding, some post-translational modifications

  • System: Baculovirus expression vector system

  • Considerations: Longer production time, higher cost

• Plant expression systems:

  • Advantages: Native post-translational modifications

  • Methods: Agroinfiltration in Nicotiana benthamiana

  • Applications: Especially useful for functional studies

• Domain-specific expression:

  • Express unique regions rather than full-length protein

  • Avoid conserved RING domain if seeking specificity against other RGLG proteins

The successful expression of GST-RGLG5 for ubiquitination assays suggests similar approaches may work for RGLG3.

What are the critical factors to consider when using anti-RGLG3 antibodies for immunolocalization studies?

For successful immunolocalization of RGLG3:

• Fixation optimization:

  • Test multiple fixatives (paraformaldehyde, glutaraldehyde)

  • Optimize fixation time to preserve structure while maintaining epitope accessibility

• Antigen retrieval methods:

  • Heat-induced epitope retrieval

  • Enzymatic retrieval

  • pH-dependent retrieval

• Reducing background:

  • Pre-absorption with plant extract from rglg3 knockout

  • Optimize blocking conditions (BSA, normal serum, plant-specific blockers)

  • Include appropriate controls (peptide competition)

• Co-localization studies:

  • Include markers for cellular compartments

  • Consider dual labeling with interacting partners

• Signal amplification methods:

  • Tyramide signal amplification for low-abundance targets

  • Quantum dot conjugates for increased sensitivity

How can mass spectrometry be integrated with immunoprecipitation to identify RGLG3 substrates?

Combining immunoprecipitation with mass spectrometry offers powerful insights into RGLG3 function:

• IP-MS workflow for RGLG3:

  • Perform IP using anti-RGLG3 antibodies

  • Process samples for LC-MS/MS analysis

  • Compare results with control IPs

• Substrate identification strategies:

  • Compare ubiquitinome of wild-type and rglg3 mutants

  • Use tandem ubiquitin binding entities (TUBEs) to enrich ubiquitinated proteins

  • Apply proximity labeling (BioID or TurboID fused to RGLG3)

• Data analysis considerations:

  • Filter for proteins enriched in treatment conditions

  • Cross-reference with jasmonate-responsive proteins

  • Validate top candidates with direct ubiquitination assays

• Technical considerations:

  • Use SILAC or TMT labeling for quantitative comparison

  • Consider crosslinking to capture transient interactions

  • Include proteasome inhibitors to stabilize ubiquitinated proteins

The successful identification of PP2CA as an interacting partner of RGLG5 using Y2H followed by coIP/mass spectrometry provides a model approach.

What quality control metrics should be applied when validating a new batch of anti-RGLG3 antibodies?

Rigorous quality control is essential for antibody reproducibility:

• Initial characterization:

  • ELISA against immunizing peptide/protein

  • Western blot against recombinant protein and plant extracts

  • Comparison with previous antibody batches

• Specificity testing:

  • Western blot on extracts from wild-type vs. rglg3 mutant plants

  • Cross-reactivity with recombinant RGLG1, 2, 4, and 5

  • Peptide competition assays

• Functional validation:

  • Immunoprecipitation efficiency

  • Ability to detect expected changes in response to jasmonate treatment

  • Immunolocalization pattern consistency

• Documentation requirements:

  • Detailed validation data

  • Optimal working dilutions for different applications

  • Storage conditions and shelf-life determination

How can I design experiments to study the dynamics of RGLG3 in response to biotic and abiotic stresses?

Experimental design for studying RGLG3 dynamics:

• Time-course experiments:

  • Harvest tissues at multiple time points after stress application

  • Include appropriate hormone treatments (jasmonates, ethylene)

  • Monitor both protein levels (westerns) and subcellular localization (immunofluorescence)

• Stress treatments to consider:

  • Pathogen infection (biotrophic and necrotrophic)

  • Wounding

  • Drought (similar to conditions where WOX5 plays a role )

  • Salt stress

  • Oxidative stress (H₂O₂ treatment)

• Protein stability assessment:

  • Cycloheximide chase assays to determine half-life

  • Comparison of stability under different stress conditions

  • Monitoring of ubiquitination status

• Interaction dynamics:

  • Bimolecular fluorescence complementation (BiFC) under different conditions

  • Förster resonance energy transfer (FRET) for real-time interaction monitoring

  • Co-immunoprecipitation after stress treatments

• Data analysis approaches:

  • Quantitative western blot analysis

  • Correlation with gene expression changes

  • Integration with phenotypic data